CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD(+)/NADH ratio
CYP3A5 通过精细调节 NAD(+)/NADH 比值来促进胶质母细胞瘤干性和化疗耐药性。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-024-03254-x
Hu, Wentao; Cui, Xiaoteng; Liu, Hongyu; Li, Ze; Chen, Xu; Wang, Qixue; Zhang, Guolu; Wen, Er; Lan, Jinxin; Chen, Junyi; Liu, Jialin; Kang, Chunsheng; Chen, Ling